With your own knowledge and the help of the following document:

Document 1 (Title: Analytical Detection Technologies in Chromatographic Methods): Detector technology represents a critical component determining analytical capabilities in modern separation science applications. Diode array detection has emerged as a particularly versatile approach offering distinctive advantages across various analytical contexts. Unlike traditional spectrophotometric designs utilizing monochromatic light sources with variable wavelength capabilities, diode array technology simultaneously captures complete absorption spectra using polychromatic radiation distributed across multiple photodiode elements. This fundamental architectural difference enables real-time acquisition of three-dimensional chromatographic data incorporating both retention information and full spectral profiles. Implementation considerations demonstrate significant variation between potential applications, with diode array technology demonstrating excellent compatibility with liquid chromatography systems across multiple separation modes. The detector's ability to simultaneously monitor multiple wavelengths proves particularly valuable for complex mixture analysis in pharmaceutical, environmental, and clinical applications utilizing HPLC methodologies. Integration with modern software systems enables peak purity assessments and compound identification capabilities through spectral library matching not possible with single-wavelength detection approaches. Technical limitations include reduced sensitivity compared to some alternative detector types and potential optical limitations regarding certain molecular classes. Importantly, fundamental operating principles involving condensed-phase light absorption create inherent incompatibility with gas-phase analytical techniques, including gas chromatography, where alternative detection technologies like flame ionization or mass spectrometry remain necessary. Optimal implementation typically involves careful consideration of mobile phase composition to minimize background absorption interference while maximizing analytical signal quality. These characteristics collectively position diode array detection as an information-rich detection approach optimally suited for liquid-phase separation techniques requiring multiwavelength monitoring capabilities.
Document 2 (Title: Growth promoting effects of IGF-1): The first demonstration that exogenous IGF-1 stimulates growth was the administration of purified hormone to hypophysectomised rats. After the biosynthesis of IGF-1 identical to the native hormone, trials of its use in humans were begun; first in adults and then in children. Our group was the first to introduce long term administration of biosynthetic IGF-1 to children with primary IGF-1 deficiency—primary GH insensitivity or LS. The finding that daily IGF-1 administration raises serum alkaline phosphatase, which is an indicator of osteoblastic activity, and serum procollagen, in addition to IGFBP-3, led to long term treatment. Treatment of patients with LS was also initiated in other parts of the world. The difference between us and the other groups was that we used a once daily dose, whereas the others administered IGF-1 twice daily. Table 1 compares the linear growth response of children with LS treated by four different groups. It can be seen that before treatment the mean growth velocity was 3–4.7 cm/year and that this increased after IGF-1 treatment to 8.2–9.1 cm/year, followed by a lower velocity of 5.5–6.4 cm/year in the next two years. (In GH treatment the highest growth velocity registered is also in the first year of treatment.) Figure 5 illustrates the growth response to IGF-1 in eight children during the first years of treatment. Ranke and colleagues reported that two of their patients had reached the third centile (Tanner), as did the patient of Krzisnik and Battelino; however, most patients did not reach a normal final height. The reasons may be late initiation of treatment, irregular IGF-1 administration, underdosage, etc. Ranke et al conclude that long term treatment of patients with LS promoted growth and, if treatment is started at an early age, there is a considerable potential for achieving height normalisation. Because no patient in our group was treated since early infancy to final height we cannot confirm this opinion. When the growth response to GH treatment in infants with IGHD was compared with that of IGF-1 in infants with LS we found that the infants with IGHD responded faster and better than those with LS. However, the small number of patients and the differences in growth retardation between the two groups makes it difficult to reach a conclusion. Both hormones stimulated linear growth, but GH seemed more effective than IGF-1. One cause may be the greater growth deficit of the infants with LS than those with IGHD, an insufficient dose of IGF-1, or that there is a need for some GH to provide an adequate stem cell population of prechondrocytes to enable full expression of the growth promoting action of IGF-1, as postulated by Green and colleagues and Ohlson et al. All the above findings based on a few clinical studies with small groups of patients and a few experimental studies remain at present controversial. The crucial question is whether there are any, and if so, whether there are sufficient IGF-1 receptors in the “progenitor cartilage zone” of the epiphyseal cartilage to respond to endocrine and exogenous IGF-1. Using the mandibular condyle of 2 day old ICR mice, Maor et al showed that these condyles, which resemble the epiphyseal plates of the long bones, contain IGF-1 and high affinity IGF-1 receptors also in the chondroprogenitor cell layers, which enables them to respond to IGF-1 in vitro. Sims et al, using mice with GH receptor KO, showed that IGF-1 administration stimulates the growth (width) of the tibial growth plate and that IGF-1 has a GH independent effect on the growth plate. These findings are similar to those found when treating hypophysectomised rats with IGF-1. In conclusion, IGF-1 is an important growth hormone, mediating the anabolic and linear growth promoting effect of pituitary GH protein. It has a GH independent growth stimulating effect, which with respect to cartilage cells is possibly optimised by the synergistic action with GH.
Document 3 (Title: Principles and Applications of Modern Chromatographic Separations): Reversed-phase chromatography represents the predominant separation mode in contemporary analytical and preparative liquid chromatography applications. The fundamental separation mechanism involves differential partitioning between a non-polar stationary phase and relatively polar mobile phase—representing an inversion of the traditional normal-phase approach. Contemporary implementations typically employ chemically modified silica substrates with covalently bound alkyl chains (typically C8 or C18) rather than unmodified silica, creating the hydrophobic interaction surface necessary for reversed-phase retention. The method characteristically employs hydro-organic mobile phases combining water with miscible organic modifiers such as methanol or acetonitrile in variable proportions, enabling powerful gradient elution capabilities. A particularly valuable feature involves compatibility with ionized analytes when appropriate mobile phase modifiers including buffers, ion-pairing reagents, or pH adjustments are incorporated—expanding applicability beyond solely neutral compounds. The elution order in reversed-phase systems follows a distinctive pattern where highly polar, hydrophilic compounds elute earliest with minimal retention, while non-polar substances experience stronger stationary phase interactions resulting in extended retention times. This predictable elution sequence contrasts directly with normal-phase approaches, which demonstrate opposite elution patterns. The versatility regarding compound polarity, ionization state, and molecular weight has established reversed-phase chromatography as the predominant separation technique for pharmaceutical analysis, environmental monitoring, clinical diagnostics, and natural product characterization. Implementation considerations include stationary phase selection, mobile phase optimization, and appropriate instrumentation configuration to maximize separation efficiency for specific analytical challenges.

Answer the following list question.
Question: Among the following statements, which one(s) is (are) correct? A diode array detector is a detector:
Options:
1. Spectrophotometric using monochromatic light
2. Spectrophotometric using polychromatic light
3. Refractometric
4. Usable in gas chromatography
5. Usable in liquid chromatography

Respond strictly in valid JSON format as shown below:
{"answer": ["1", "3"]} ← if options 1 and 3 are correct
Only output the JSON object. Do not include explanations, labels, markdown, or any other text.